Delivery systems for antioxidant nutrients

Toxicology

Volumn 180, Issue 2, 2002, Pages 183-193

  Takata, Jiro ^a   Matsunaga, Kazuhisa ^a   Karube, Yoshiharu ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Antioxidant nutrients; Reactive oxygen species; Vitamin K

Indexed keywords

2,7,8 TRIMETHYL(BETA CARBOXYETHYL) 6 HYDROXYCHROMAN; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; CHLORIDE; CHROMAN DERIVATIVE; DEXTRO ALPHA TOCOPHERYL N,N DIMETHYLAMINOACETATE; DEXTRO ALPHA TOCOPHERYLACETATE; DOXORUBICIN; ESTER DERIVATIVE; FARNOQUINONE; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; HYDROQUINONE; OXIDIZING AGENT; PHYTOMENADIONE; PRODRUG; REACTIVE OXYGEN METABOLITE; RICINOMACROGOL; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ANAPHYLAXIS; ARTICLE; CARDIOTOXICITY; CELL FUNCTION; DRUG ACTIVATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; EMULSION; HUMAN; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; HUMANS; MICE; PRODRUGS; RATS; REACTIVE OXYGEN SPECIES; VITAMIN E; VITAMIN K;

EID: 0037110637     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00390-6     Document Type: Article

References (89)

1. Allison A.C., Eugui E.M. Induction of cytokine formation by bacteria and their products. Roth J.A., Virulence Mechanisms of Bacterial Pathogens. 1995;303-332 American Society for Microbiology, Washington, DC.
2. Amstad P.A., Krupitza G., Cerutti P.A. Mechanism of c-fos induction by active oxygen. Cancer Res. 52:1992;3952-3960.
3. Atallah A.S., Landolph J.R., Ernster L., Hochstein P. DT-diaphorase activity and the cytotoxicity of quinones in C3H/10T1/2 mouse embryo cells. Biochem. Pharmacol. 37:1988;2451-2459.
4. Badr M.Z., Yoshihara H., Kauffman F.C., Thurman R.G. Menadione causes selective toxicity to preportal regions of the liver lobule. Toxicol. Lett. 35:1987;241-246.
5. Badr M.Z., Ganey P.E., Yoshihara H., Kauffman F.C., Thurman R.G. Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule. J. Pharmacol. Exp. Ther. 248:1989;1317-1322.
6. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
7. Bell E.F., Brown E.J., Milner R., Sinclair J.C., Zipursky A. Vitamin E absorption in small premature infants. Pediatrics. 63:1979;830-832.
8. Bieri J.G., Evarts R.P. Vitamin E activity of α-tocopherol in the rat, chick and hamster. J. Nutr. 104:1974;850-857.
9. Bieri J.G., Corash L., Hubbard V.S. Medical uses of vitamin E. N. Engl. J. Med. 308:1983;1063-1071.
10. Borzotta A.P., Polk H.C. Jr. Multiple system organ failure. Surg. Clin. North Am. 63:1983;315-336.
11. Bradley S.G. Cellular and molecular mechanisms of action of bacterial endotoxins. Annu. Rev. Microbiol. 33:1979;67-94.
12. Brawn M.K., Chiou W.J., Leach K.L. Oxidant-induced activation of protein-kinase-C in UC11MG cells. Free Radic. Res. 22:1995;23-37.
13. Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α Proc. Natl. Acad. Sci. USA. 90:1993;2532-2536.
14. Burton G.W., Ingold K.U. Autoxidation of biological molecules. I. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc. 103:1981;6472-6477.
15. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., Ames B.N. γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: physiological implications. Proc. Natl. Acad. Sci. USA. 94:1997;3217-3222.
16. Cooney R.V., Harwood P.J., Franke A.A., Hatch-Pigott V., Custer L.J., Mordan L.J. γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc. Natl. Acad. Sci. USA. 90:1993;1771-1775.
17. 2 and their formation in rat insulinoma (RINm5F) cells. Free Radic. Biol. Med. 19:1995;259-269.
18. Devary Y., Rosette C., DiDonato J.A., Karin M. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science. 261:1993;1442-1445.
19. Fialkow L., Chan C.K., Rotin D., Grinstein S., Downey G.P. Activation of the mitogen-activated protein-kinase signaling pathway in neutrophils: role of oxidants. J. Biol. Chem. 269:1994;31234-31242.
20. Galaris D., Georgellis A., Rydstrom J. Toxic effects of daunorubicin on isolated and cultured heart cells from neonatal rats. Biochem. Pharmacol. 34:1985;989-995.
21. Grisar J.M., Petty M.A., Bolkenius F.N., Dow J., Wagner J., Wagner E.R., Haegele K.D., DeJong W. A Cardioselective, hydrophilic N,N,N-trimethylethanaminium α-tocopherol analog that reduces myocardial infarct size. J. Med. Chem. 34:1991;257-260.
22. Handel M.L., McMorrow L.B., Gravallese E.M. Nuclear factor-κB in rheumatoid synovium: localization of p50 and p65. Arthritis Rheum. 38:1995;1762-1770.
23. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
24. Horton A.A., Fairhurst S. Lipid peroxidation and mechanisms of toxicity. CRC Crit. Rev. Toxicol. 18:1987;27-79.
25. Ito H., Miller S.C., Billingham M.E., Akimoto H., Torti S.V., Wade R., Gahlmann R., Lyons G., Kedes L., Torti F.M. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 87:1990;4275-4279.
26. Jacobson M.D., Raff M.C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature. 374:1995;814-816.
27. Jiang Q., Elson-Schwab I., Courtemanche C., Ames B.N. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA. 97:2000;11494-11499.
28. 2-secreted by monocytes and macrophages. Methods Enzymol. 12:1994;141-179.
29. Kaltschmidt B., Baeuerle P.A., Kaltschmidt C. Potential involvement of the transcription factor NF-κB in neurological disorders. Mol. Aspects Med. 14:1993;171-190.
30. Keyse S.M., Emslie E.A. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature. 359:1992;644-647.
31. Keyse S.M., Tyrrell R.M. Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: Evidence for the involvement of the hydroxyl radical. Carcinogenesis. 11:1990;787-791.
32. Kontush A., Spranger T., Reich A., Baum K., Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of α-carotene and γ-tocopherol. Atherosclerosis. 144:1999;117-122.
33. Kristenson M., Zieden B., Kucinskiene Z., Elinder L.S., Bergdahl B., Elwing B., Abaravicius A., Razinkoviene L., Calkauskas H., Olsson A.G. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. Br. Med. J. 314:1997;629-633.
34. Lefrak E.A., Pitha J., Rosenheim S., Gottlieb J.A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 32:1973;302-314.
35. Lehmann J., Martin H.L., Lashley E.L., Marshall M.W., Judd J.T. Vitamin E in foods from high and low linoleic acid diets. J. Am. Diet. Assoc. 86:1986;1208-1216.
36. Lennon S.V., Martin S.J., Cotter T.G. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell. Prolif. 24:1991;203-214.
37. Liao F., Andalibi A., deBeer F.C., Fogelman A.M., Lusis A.J. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91:1993;2572-2579.
38. MacMahon M.T., Thompson G.R. Comparison of absorption of a polar lipid, oleic acid, and a non-polar lipid, α-tocopherol from mixed micellar solutions and emulsions. Eur. J. Clin. Invest. 1:1970;161-166.
39. Martone W.J., Williams W.W., Mortensen M.L., Gaynes R.P., White J.W., Lorch V., Murphy M.D., Sinha S.N., Frank D.J., Kosmetatos N., Bodenstein C.J., Robert R.J. Illness with fatalities in premature infants: association with an intravenous vitamin E preparation, E-ferol. Pediatrics. 78:1986;591-600.
40. Marubayashi S., Dohi K., Ochi K., Kawasaki T. Role of free radicals in ischemic rat liver cell injury: prevention of damage by α-tocopherol administration. Surgery. 99:1986;184-192.
41. Massey K.D., Burton K.P. Tocopherol attenuates myocardial membrane-related alterations resulting from ischemia and reperfusion. Am. J. Physiol. 256:1989;H1192-1199.
42. Mickle D.A., Li R.K., Weisel R.D., Birnbaum P.L., Wu T.W., Jackowski G., Madonik M.M., Burton G.W., Ingold K.U. Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. Ann. Thorac. Surg. 47:1989;553-557.
43. Mimnaugh E.G., Siddik Z.H., Drew R., Sikic B.I., Gram T.E. The effects of α-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice. Toxicol. Appl. Pharmacol. 49:1979;119-126.
44. Minow R.A., Benjamin R.S., Gottlieb J.A. Adriamycin (NSC-123127) cardiomyopathy: an overview with determination of risk factors. Cancer Chemother. Rep. 6:1975;195-201.
45. Morrison H., Di Monte D., Nordenskjöld M., Jernström B. Induction of cell damage by menadione and benzo(a)pyrene-3,6-quinone in cultures of adult rat hepatocytes and human fibroblasts. Toxicol. Lett. 28:1985;37-47.
46. Morselli P.L., Franco-Morselli R., Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin. Pharmacokinet. 5:1980;485-527.
47. Myers C.E. Anthracyclines. Cancer Chemother. Biol. Resp. Modifiers Annu. 10:1988;33-39.
48. Myers C.E., McGuire W.P., Young R. Adriamycin: amelioration of toxicity by α-tocopherol. Cancer Treat. Rep. 60:1976;961-962.
49. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 197:1977;165-167.
50. Nagata Y., Takata J., Karube Y., Matsushima Y. Effects of a water soluble prodrug of vitamin E on doxorubicin-induced toxicity in mice. Biol. Pharm. Bull. 22:1999;698-702.
51. Newmark H.L., Pool W., Bauernfeind J.C., DeRitter E. Biopharmaceutic factors in parenteral administration of vitamin E. J. Pharm. Sci. 64:1975;655-657.
52. Nose K., Shibanuma M., Kikuchi K., Kageyama H., Sakiyama S., Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 201:1991;99-106.
53. Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4:1990;3076-3086.
54. Ohrvall M., Sundlof G., Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J. Intern. Med. 239:1996;111-117.
55. 1 in relation to anticoagulant poisoning. Br. J. Clin. Pharmacol. 18:1984;655-662.
56. Pedraz J.L., Calvo B., Bortolotti A., Celardo A., Bonati M. Bioavailability of intramuscular vitamin E acetate in rabbits. J. Pharm. Pharmacol. 41:1989;415-417.
57. Reynolds, J.E.F. (Ed.), 1989. Martindale: The Extra Pharmacopoeia. 29th edition, The Pharmaceutical Press, London, pp. 1285-1287.
58. Riley R.J., Workman P. DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol. 43:1992;1657-1669.
59. Sakaguchi S., Kanda N., Hsu C.C., Sakaguchi O. Lipid peroxide formation and membrane damage in endotoxin-poisoned mice. Microbiol. Immunol. 25:1981;229-244.
60. Saran M., Bors W. Oxygen radicals acting as chemical messengers: a hypothesis. Free Radic. Res. Commun. 7:1989;213-220.
61. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad. Res. Commun. 17:1992;221-237.
62. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
63. Siegel J.H. Cardiorespiratory manifestations of metabolic failure in sepsis and the multiple organ failure syndrome. Surg. Clin. North Am. 63:1983;379-399.
64. Sinha B.K. Free radicals in anticancer drug pharmacology. Chem. Biol. Interact. 69:1989;293-317.
65. Sinha B.K., Politi P.M. Anthracyclines. Cancer Chemother. Biol. Resp. Modifiers Annu. 11:1990;45-57.
66. Smith M.T., Evance C.G., Thor H., Orrenius S. Quinone induced oxidative injury to cell and tissues. Sies H., Oxidative Stress. 1985;91-113 Academic Press, London.
67. Staal F.J.T., Roederer M., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:1990;9943-9947.
68. Stein B., Yang M.X. Repression of the interleukin-6 promotor by estrogen receptor is mediated by NF-κB and C/EBP β Mol. Cell. Biol. 15:1995;4971-4979.
69. Sugino K., Dohi K., Yamada K., Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery. 101:1987;746-752.
70. Suttie J.W. Mechanism of action of vitamin K: synthesis of γ-carboxyglutamic acid. CRC Crit. Rev. Biochem. 8:1980;191-223.
71. Suttie J.W. Vitamin K-dependent carboxylase. Annu. Rev. Biochem. 54:1985;459-477.
72. Suzuki Y.J., Packer L. Inhibition of NF-kB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
73. Suzuki Y.J., Packer L. Inhibition of NF-kB DNA binding activity by alpha-tocopheryl succinate. Biochem. Mol. Biol. Int. 31:1994;693-700.
74. Takata J., Karube Y., Hanada M., Matsunaga K., Matsushima Y., Sendo T., Aoyama T. Vitamin K prodrugs: 1. Synthesis of amino acid esters of menahydroquinone-4 and enzymatic reconversion to an active form. Pharm. Res. 12:1995a;18-23.
75. Takata J., Karube Y., Nagata Y., Matsushima Y. Prodrugs of Vitamin E. 1. Preparation and enzymatic hydrolysis of aminoalkanecarboxylic acid esters of d-α-tocopherol. J. Pharm. Sci. 84:1995b;96-100.
76. Takata J., Ito S., Karube Y., Nagata Y., Matsushima Y. Water-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicity. Biol. Pharm. Bull. 20:1995c;204-209.
77. Takata J., Karube Y., Hanada M., Matsunaga K., Matsushima Y., Sendo T., Oishi R. Vitamin K prodrugs: 2. Water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery. Pharm. Res. 12:1995d;1973-1979.
78. Takata J., Karube Y., Hanada M., Matsunaga K., Matsushima Y. Bioreductive activation-independent delivery of menahydroquinone-4 via prodrug and its action in warfarin-poisoned rat liver. Pharm. Sci. 2:1996;571-576.
79. Takata J., Karube Y., Hanada M., Matsunaga K., Iwasaki H. Prodrug for bioreductive activation-independent delivery of menahydroquinone-4: human liver enzymatic activation and its action in warfarin-poisoned human liver. Biol. Pharm. Bull. 22:1999a;172-178.
80. Takata J., Karube Y., Matsunaga K., Hanada M., Hidaka R., Matsushima Y. Prodrug for systemic bioreductive activation-independent delivery of phyllohydroquinone, an active form of phylloquinone (vitamin K1) 1: preparation and in vitro evaluation. Biol. Pharm. Bull. 22:1999b;1347-1354.
81. Thor H., Smith M.T., Hartzell P., Bellomo G., Jewell S.A., Orrenius S. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes: a study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257:1982;12419-12425.
82. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;4328-4332.
83. Wallin R., Martin L.F. Warfarin poisoning and vitamin K antagonism in rat and human liver: design of a system in vitro that mimics the situation in vivo. Biochem. J. 241:1987;389-396.
84. Wechter W.J., Kantoci D., Murray E.D. Jr, D'Amico D.C., Jung M.E., Wang W.H. A new endogenous natriuretic factor: LLU-α Proc. Natl. Acad. Sci. USA. 93:1996;6002-6007.
85. Weisel R.D., Mickle D.A.G., Finkle C.D., Tumiati L.C., Madonik M.M., Ivanov J., Burton G.W., Ingold K.U. Myocardial free-radical injury after cardioplegia. Circulation. 80:1989;III14-III18.
86. Whisler R.L., Goyette M.A., Grants I.S., Newhouse Y.G. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T-cells. Arch. Biochem. Biophys. 319:1995;23-35.
87. Willis D., Moore A.R., Frederick R., Willoughby D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:1996;87-90.
88. Winyard P.G., Blake D.R. Antioxidants, redox-regulated transciption factors, and inflammation. Adv. Pharmacol. 38:1997;403-421.
89. Young R.C., Ozols R.F., Myers C.E. Medical progress. The anthracycline antineoplastic drugs. N. Engl. J. Med. 305:1981;139-153.